詳細検索

詳細検索

お問い合わせ

Enterprise Imaging IT Market by Function, Modality, Application, Therapy, End User, Region - Global Forecast to 2031

Enterprise Imaging IT Market by Function, Modality, Application, Therapy, End User, Region - Global Forecast to 2031


The global enterprise imaging IT market is projected to reach USD 4.59 billion by 2031, up from USD 2.58 billion in 2026, at a CAGR of 12.2% from 2026 to 2031. Growth in the enterprise imaging IT ... もっと見る

 

 

出版社
MarketsandMarkets
マーケッツアンドマーケッツ
出版年月
2026年10月29日
電子版価格
US$4,950
シングルユーザーライセンス
ライセンス・価格情報/注文方法はこちら
納期
通常2営業日以内
ページ数
421
図表数
420
言語
英語

英語原文をAIを使って翻訳しています。


 

お問い合わせ

お問合せ種類/内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る



図表リスト

FIGURE 1 ENTERPRISE IMAGING IT MARKET SEGMENTATION & REGIONAL SCOPE 34.
FIGURE 2 MARKET SCENARIO 40.
FIGURE 3 GLOBAL ENTERPRISE IMAGING IT MARKET, 2024–2031 40.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET, 2023–2026 41.
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF ENTERPRISE IMAGING IT MARKET 42.
FIGURE 6 HIGH-GROWTH SEGMENTS IN ENTERPRISE IMAGING IT MARKET, 2026–2031 43.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ENTERPRISE IMAGING IT MARKET DURING FORECAST PERIOD 44.
FIGURE 8 RISING IN IMAGING VOLUMES TO DRIVE GROWTH IN ENTERPRISE.
IMAGING IT MARKET 45.
FIGURE 9 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE.
IN NORTH AMERICA IN 2025 46.
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 47.
FIGURE 11 ENTERPRISE IMAGING IT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,.
AND CHALLENGES 48.
FIGURE 12 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2026 54.
FIGURE 13 US: MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR, 2008–2028 54.
FIGURE 14 ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS 67.
FIGURE 15 ENTERPRISE IMAGING IT MARKET: VALUE CHAIN ANALYSIS 72.
FIGURE 16 ENTERPRISE IMAGING IT MARKET: ECOSYSTEM ANALYSIS 74.
FIGURE 17 REVENUE SHIFT IN ENTERPRISE IMAGING IT MARKET 79.
FIGURE 18 RECENT FUNDING OF PLAYERS IN ENTERPRISE IMAGING IT MARKET 80.
FIGURE 19 PATENT PUBLICATION TRENDS IN ENTERPRISE IMAGING IT MARKET, 2015–2026 93.
FIGURE 20 JURISDICTION AND TOP APPLICANT ANALYSIS FOR ENTERPRISE IMAGING.
IT MARKET 93.
FIGURE 21 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENTERPRISE IMAGING IT MARKET (JANUARY 2015–OCTOBER 2026) 94.
FIGURE 22 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING ENTERPRISE.
IMAGING IT ACROSS INDUSTRIES 99.
FIGURE 23 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 101.
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 115.
FIGURE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 116.
FIGURE 26 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET SNAPSHOT 182.
FIGURE 27 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET SNAPSHOT 226.
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET,.
2021–2025 (USD MILLION) 282.
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 283.
FIGURE 30 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 287.
FIGURE 31 ENTERPRISE IMAGING IT MARKET: COMPANY FOOTPRINT 288.
FIGURE 32 ENTERPRISE IMAGING IT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 295.
FIGURE 33 EV/EBITDA OF KEY VENDORS 298.
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA.
OF KEY VENDORS 298.
FIGURE 35 ENTERPRISE IMAGING IT MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 299.
FIGURE 36 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2025) 305.
FIGURE 37 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 311.
FIGURE 38 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 317.
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 325.
FIGURE 40 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 332.
FIGURE 41 SECTRA AB: COMPANY SNAPSHOT (2025) 339.
FIGURE 42 OPTUM, INC.: COMPANY SNAPSHOT (2025) 345.
FIGURE 43 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2025) 349.
FIGURE 44 PRO MEDICUS, LTD.: COMPANY SNAPSHOT (2025) 355.
FIGURE 45 MACH7 TECHNOLOGIES: COMPANY SNAPSHOT (2024) 368.
FIGURE 46 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2026) 376.
FIGURE 47 RESEARCH DESIGN 398.
FIGURE 48 PRIMARY SOURCES 400.
FIGURE 49 INSIGHTS FROM INDUSTRY EXPERTS 402.
FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,.
AND REGION 402.
FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 403.
FIGURE 52 BOTTOM-UP APPROACH 404.
FIGURE 53 TOP-DOWN APPROACH 405.
FIGURE 54 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031) 406.
FIGURE 55 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 407.
FIGURE 56 DATA TRIANGULATION METHODOLOGY 409.
TABLE 1 USD EXCHANGE RATES 37.
TABLE 2 ENTERPRISE IMAGING IT MARKET: IMPACT ANALYSIS 49.
TABLE 3 US: TOP 30 HEALTHCARE DATA BREACHES, 2011–2026 55.
TABLE 4 ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS 68.
TABLE 5 ENTERPRISE IMAGING IT MARKET: ROLE IN ECOSYSTEM 74.
TABLE 6 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT MARKET, BY OFFERING (2025) 76.
TABLE 7 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT SOLUTIONS, BY REGION (2025) 77.
TABLE 8 ENTERPRISE IMAGING IT MARKET: KEY CONFERENCES & EVENTS, 2026–2027 78.
TABLE 9 CASE STUDY 1: ENHANCING IMAGING EFFICIENCY & SECURITY WITH SECTRA’S AUTOMATED MULTIMEDIA WORKFLOW 80.
TABLE 10 CASE STUDY 2: ENTERPRISE IMAGING CONSOLIDATION AT PIEDMONT HEALTHCARE WITH HYLAND VNA 81.
TABLE 11 CASE STUDY 3: ENTERPRISE-WIDE IMAGING UNIFICATION WITH GE’S EDISON DATALOGUE AT A LEADING MEDICAL CENTER 81.
TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES 83.
TABLE 13 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR ENTERPRISE IMAGING IT MARKET 94.
TABLE 14 ENTERPRISE IMAGING IT MARKET: LIST OF PATENTS/PATENT APPLICATIONS 95.
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 105.
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106.
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 107.
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 108.
TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 108.
TABLE 20 REGULATORY SCENARIO OF NORTH AMERICA 109.
TABLE 21 REGULATORY SCENARIO OF EUROPE 110.
TABLE 22 REGULATORY SCENARIO OF ASIA PACIFIC 111.
TABLE 23 REGULATORY SCENARIO OF LATIN AMERICA 112.
TABLE 24 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 112.
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF.
TOP THREE END USERS (%) 116.
TABLE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS 117.
TABLE 27 UNMET NEEDS IN ENTERPRISE IMAGING IT MARKET 119.
TABLE 28 END USER EXPECTATIONS IN ENTERPRISE IMAGING IT MARKET 120.
TABLE 29 ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 123.
TABLE 30 VENDOR-NEUTRAL ARCHIVES (VNA) OFFERED BY KEY MARKET PLAYERS 124.
TABLE 31 ENTERPRISE IMAGING IT MARKET FOR VENDOR-NEUTRAL ARCHIVES (VNA),.
BY REGION, 2024–2031 (USD MILLION) 124.
TABLE 32 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) OFFERED.
BY KEY MARKET PLAYERS 126.
TABLE 33 ENTERPRISE IMAGING IT MARKET FOR PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY REGION, 2024–2031 (USD MILLION) 126.
TABLE 34 IMAGE EXCHANGE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 127.
TABLE 35 ENTERPRISE IMAGING IT MARKET FOR IMAGE EXCHANGE,.
BY REGION, 2024–2031 (USD MILLION) 127.
TABLE 36 UNIVERSAL VIEWERS OFFERED BY KEY MARKET PLAYERS 128.
TABLE 37 ENTERPRISE IMAGING IT MARKET FOR UNIVERSAL VIEWERS,.
BY REGION, 2024–2031 (USD MILLION) 129.
TABLE 38 WORKFLOW ORCHESTRATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 130.
TABLE 39 ENTERPRISE IMAGING IT MARKET FOR WORKFLOW ORCHESTRATION,.
BY REGION, 2024–2031 (USD MILLION) 130.
TABLE 40 ANALYTICS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 131.
TABLE 41 ENTERPRISE IMAGING IT MARKET FOR ANALYTICS, BY REGION,.
2024–2031 (USD MILLION) 131.
TABLE 42 ENTERPRISE IMAGING IT MARKET FOR OTHER FUNCTIONS,.
BY REGION, 2024–2031 (USD MILLION) 132.
TABLE 43 ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024–2031 (USD MILLION) 134.
TABLE 44 ENTERPRISE IMAGING IT MARKET FOR X-RAY, BY REGION,.
2024–2031 (USD MILLION) 135.
TABLE 45 ENTERPRISE IMAGING IT MARKET FOR MRI, BY REGION,.
2024–2031 (USD MILLION) 137.
TABLE 46 ENTERPRISE IMAGING IT MARKET FOR CT, BY REGION,.
2024–2031 (USD MILLION) 138.
TABLE 47 ENTERPRISE IMAGING IT MARKET FOR ULTRASOUND, BY REGION,.
2024–2031 (USD MILLION) 139.
TABLE 48 ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,.
2024–2031 (USD MILLION) 140.
TABLE 49 ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY REGION,.
2024–2031 (USD MILLION) 141.
TABLE 50 ENTERPRISE IMAGING IT MARKET FOR PET, BY REGION,.
2024–2031 (USD MILLION) 142.
TABLE 51 ENTERPRISE IMAGING IT MARKET FOR SPECT, BY REGION,.
2024–2031 (USD MILLION) 142.
TABLE 52 ENTERPRISE IMAGING IT MARKET FOR ENDOSCOPY, BY REGION,.
2024–2031 (USD MILLION) 143.
TABLE 53 ENTERPRISE IMAGING IT MARKET FOR MAMMOGRAPHY, BY REGION,.
2024–2031 (USD MILLION) 144.
TABLE 54 ENTERPRISE IMAGING IT MARKET FOR FLUOROSCOPY, BY REGION,.
2024–2031 (USD MILLION) 146.
TABLE 55 ENTERPRISE IMAGING IT MARKET FOR ECHOCARDIOGRAPHY,.
BY REGION, 2024–2031 (USD MILLION) 147.
TABLE 56 ENTERPRISE IMAGING IT MARKET FOR OTHER MODALITIES,.
BY REGION, 2024–2031 (USD MILLION) 148.
TABLE 57 ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 150.
TABLE 58 ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC APPLICATIONS,.
BY REGION, 2024–2031 (USD MILLION) 151.
TABLE 59 ENTERPRISE IMAGING IT MARKET FOR THERAPEUTIC APPLICATIONS,.
BY REGION, 2024–2031 (USD MILLION) 152.
TABLE 60 ENTERPRISE IMAGING IT MARKET FOR CLINICAL RESEARCH APPLICATIONS,.
BY REGION, 2024–2031 (USD MILLION) 153.
TABLE 61 ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 155.
TABLE 62 ENTERPRISE IMAGING IT MARKET FOR SOFTWARE, BY REGION,.
2024–2031 (USD MILLION) 156.
TABLE 63 ENTERPRISE IMAGING IT MARKET FOR SERVICES, BY REGION,.
2024–2031 (USD MILLION) 157.
TABLE 64 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 159.
TABLE 65 ENTERPRISE IMAGING IT MARKET FOR ON-PREMISES SOLUTIONS,.
BY REGION, 2024–2031 (USD MILLION) 160.
TABLE 66 ENTERPRISE IMAGING IT MARKET FOR CLOUD-BASED SOLUTIONS,.
BY REGION, 2024–2031 (USD MILLION) 161.
TABLE 67 ENTERPRISE IMAGING IT MARKET FOR HYBRID SOLUTIONS,.
BY REGION, 2024–2031 (USD MILLION) 162.
TABLE 68 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 164.
TABLE 69 ENTERPRISE IMAGING IT MARKET FOR NEUROLOGY, BY REGION,.
2024–2031 (USD MILLION) 165.
TABLE 70 ENTERPRISE IMAGING IT MARKET FOR CARDIOLOGY, BY REGION,.
2024–2031 (USD MILLION) 166.
TABLE 71 ENTERPRISE IMAGING IT MARKET FOR ONCOLOGY, BY REGION,.
2024–2031 (USD MILLION) 168.
TABLE 72 ENTERPRISE IMAGING IT MARKET FOR ORTHOPEDICS, BY REGION,.
2024–2031 (USD MILLION) 169.
TABLE 73 ENTERPRISE IMAGING IT MARKET FOR OTHER THERAPEUTIC AREAS,.
BY REGION, 2024–2031 (USD MILLION) 169.
TABLE 74 ENTERPRISE IMAGING IT MARKET, FOR END USER, 2024–2031 (USD MILLION) 171.
TABLE 75 ENTERPRISE IMAGING IT MARKET FOR HOSPITALS, BY REGION,.
2024–2031 (USD MILLION) 172.
TABLE 76 ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC CENTERS,.
BY REGION, 2024–2031 (USD MILLION) 173.
TABLE 77 ENTERPRISE IMAGING IT MARKET FOR CLINICS & OUTPATIENT SETTINGS,.
BY REGION, 2024–2031 (USD MILLION) 174.
TABLE 78 ENTERPRISE IMAGING IT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 175.
TABLE 79 ENTERPRISE IMAGING IT MARKET FOR MEDTECH COMPANIES,.
BY REGION, 2024–2031 (USD MILLION) 176.
TABLE 80 ENTERPRISE IMAGING IT MARKET FOR RESEARCH & ACADEMIC INSTITUTES,.
BY REGION, 2024–2031 (USD MILLION) 178.
TABLE 81 ENTERPRISE IMAGING IT MARKET FOR OTHER END USERS,.
BY REGION, 2024–2031 (USD MILLION) 179.
TABLE 82 ENTERPRISE IMAGING IT MARKET, BY REGION, 2024–2031 (USD MILLION) 181.
TABLE 83 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 183.
TABLE 84 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 183.
TABLE 85 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 184.
TABLE 86 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 184.
TABLE 87 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 185.
TABLE 88 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 185.
TABLE 89 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 185.
TABLE 90 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 186.
TABLE 91 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 186.
TABLE 92 US: KEY MACROINDICATORS 188.
TABLE 93 US: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 188.
TABLE 94 US: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024–2031 (USD MILLION) 189.
TABLE 95 US: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 189.
TABLE 96 US: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 190.
TABLE 97 US: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 190.
TABLE 98 US: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 190.
TABLE 99 US: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 191.
TABLE 100 US: ENTERPRISE IMAGING IT MARKET, BY END USER, 2024–2031 (USD MILLION) 191.
TABLE 101 CANADA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 193.
TABLE 102 CANADA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 193.
TABLE 103 CANADA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 194.
TABLE 104 CANADA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 194.
TABLE 105 CANADA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 194.
TABLE 106 CANADA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 195.
TABLE 107 CANADA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 195.
TABLE 108 CANADA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 196.
TABLE 109 EUROPE: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 197.
TABLE 110 EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 197.
TABLE 111 EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 198.
TABLE 112 EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 198.
TABLE 113 EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 199.
TABLE 114 EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 199.
TABLE 115 EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 199.
TABLE 116 EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 200.
TABLE 117 EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 200.
TABLE 118 GERMANY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 202.
TABLE 119 GERMANY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 202.
TABLE 120 GERMANY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 203.
TABLE 121 GERMANY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 203.
TABLE 122 GERMANY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 203.
TABLE 123 GERMANY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 204.
TABLE 124 GERMANY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 204.
TABLE 125 GERMANY: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 205.
TABLE 126 UK: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 206.
TABLE 127 UK: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024–2031 (USD MILLION) 206.
TABLE 128 UK: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 129 UK: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 207.
TABLE 130 UK: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 207.
TABLE 131 UK: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 208.
TABLE 132 UK: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 208.
TABLE 133 UK: ENTERPRISE IMAGING IT MARKET, BY END USER, 2024–2031 (USD MILLION) 209.
TABLE 135 FRANCE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 210.
TABLE 136 FRANCE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 210.
TABLE 137 FRANCE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 138 FRANCE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 211.
TABLE 139 FRANCE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 211.
TABLE 140 FRANCE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 212.
TABLE 141 FRANCE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 212.
TABLE 142 FRANCE: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 213.
TABLE 144 ITALY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 214.
TABLE 145 ITALY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 214.
TABLE 146 ITALY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 147 ITALY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 215.
TABLE 148 ITALY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 215.
TABLE 149 ITALY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 216.
TABLE 150 ITALY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 216.
TABLE 151 ITALY: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 217.
TABLE 152 SPAIN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 218.
TABLE 153 SPAIN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 218.
TABLE 154 SPAIN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 155 SPAIN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 219.
TABLE 156 SPAIN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 219.
TABLE 157 SPAIN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 220.
TABLE 158 SPAIN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 220.
TABLE 159 SPAIN: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 221.
TABLE 160 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 222.
TABLE 161 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 222.
TABLE 163 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 164 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 223.
TABLE 165 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 223.
TABLE 166 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 224.
TABLE 167 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 224.
TABLE 168 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 225.
TABLE 169 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 227.
TABLE 170 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 227.
TABLE 171 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 228.
TABLE 172 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 228.
TABLE 173 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 229.
TABLE 174 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 229.
TABLE 175 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 229.
TABLE 176 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 230.
TABLE 177 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 230.
TABLE 178 CHINA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 231.
TABLE 179 CHINA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 232.
TABLE 180 CHINA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 232.
TABLE 181 CHINA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 233.
TABLE 182 CHINA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 233.
TABLE 183 CHINA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 233.
TABLE 184 CHINA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 234.
TABLE 185 CHINA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 234.
TABLE 186 JAPAN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 236.
TABLE 187 JAPAN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 236.
TABLE 188 JAPAN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 237.
TABLE 189 JAPAN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 237.
TABLE 190 JAPAN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 237.
TABLE 191 JAPAN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 238.
TABLE 192 JAPAN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 238.
TABLE 193 JAPAN: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 239.
TABLE 194 INDIA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 240.
TABLE 195 INDIA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 240.
TABLE 196 INDIA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 241.
TABLE 197 INDIA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 241.
TABLE 198 INDIA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 241.
TABLE 199 INDIA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 242.
TABLE 200 INDIA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 242.
TABLE 201 INDIA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 243.
TABLE 202 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 244.
TABLE 203 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 244.
TABLE 204 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 245.
TABLE 205 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 245.
TABLE 206 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 245.
TABLE 207 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 246.
TABLE 208 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 246.
TABLE 209 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 247.
TABLE 210 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 248.
TABLE 211 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 248.
TABLE 212 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 249.
TABLE 213 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 249.
TABLE 214 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 250.
TABLE 215 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 250.
TABLE 216 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 250.
TABLE 217 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 251.
TABLE 218 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 251.
TABLE 219 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 252.
TABLE 220 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 253.
TABLE 221 BRAZIL: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 253.
TABLE 222 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 254.
TABLE 223 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 254.
TABLE 224 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 254.
TABLE 225 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 255.
TABLE 226 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 255.
TABLE 227 MEXICO: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 257.
TABLE 228 MEXICO: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 257.
TABLE 229 MEXICO: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 258.
TABLE 230 MEXICO: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 258.
TABLE 231 MEXICO: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 258.
TABLE 232 MEXICO: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 259.
TABLE 233 MEXICO: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 259.
TABLE 234 MEXICO: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 260.
TABLE 235 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 261.
TABLE 236 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY MODALITY, 2024–2031 (USD MILLION) 261.
TABLE 237 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 262.
TABLE 238 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 262.
TABLE 239 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 262.
TABLE 240 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 263.
TABLE 241 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 263.
TABLE 242 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 264.
TABLE 243 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY COUNTRY, 2024–2031 (USD MILLION) 265.
TABLE 244 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 266.
TABLE 245 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY MODALITY, 2024–2031 (USD MILLION) 266.
TABLE 246 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 267.
TABLE 247 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 267.
TABLE 248 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 267.
TABLE 249 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 268.
TABLE 250 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 268.
TABLE 251 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 269.
TABLE 252 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 270.
TABLE 253 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 270.
TABLE 254 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 271.
TABLE 255 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 271.
TABLE 256 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 271.
TABLE 257 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 272.
TABLE 258 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 272.
TABLE 259 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 273.
TABLE 260 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 274.
TABLE 261 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY MODALITY, 2024–2031 (USD MILLION) 274.
TABLE 262 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 275.
TABLE 263 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 275.
TABLE 264 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 275.
TABLE 265 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 276.
TABLE 266 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 276.
TABLE 267 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 277.
TABLE 268 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023–2026 279.
TABLE 269 ENTERPRISE IMAGING IT MARKET: DEGREE OF COMPETITION 283.
TABLE 270 ENTERPRISE IMAGING IT MARKET: REGION FOOTPRINT 289.
TABLE 271 ENTERPRISE IMAGING IT MARKET: FUNCTION FOOTPRINT 290.
TABLE 272 ENTERPRISE IMAGING IT MARKET: APPLICATION FOOTPRINT 291.
TABLE 273 ENTERPRISE IMAGING IT MARKET: THERAPEUTIC FOOTPRINT 292.
TABLE 274 ENTERPRISE IMAGING IT MARKET: DEPLOYMENT FOOTPRINT 293.
TABLE 275 ENTERPRISE IMAGING IT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 296.
TABLE 276 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 296.
TABLE 277 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY FUNCTION 297.
TABLE 278 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY THERAPEUTIC AREA 297.
TABLE 279 ENTERPRISE IMAGING IT MARKET: SOLUTION LAUNCHES & ENHANCEMENT, JANUARY 2023–OCTOBER 2026 300.
TABLE 280 ENTERPRISE IMAGING IT MARKET: DEALS, JANUARY 2023–OCTOBER 2026 301.
TABLE 281 ENTERPRISE IMAGING IT MARKET: EXPANSIONS, JANUARY 2023–OCTOBER 2026 302.
TABLE 282 ENTERPRISE IMAGING IT MARKET: OTHER DEVELOPMENTS, JANUARY 2023–OCTOBER 2026 303.
TABLE 283 AGFA-GEVAERT GROUP: COMPANY OVERVIEW 304.
TABLE 284 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED 305.
TABLE 285 AGFA-GEVAERT GROUP: DEALS, JANUARY 2023–OCTOBER 2026 307.
TABLE 286 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 310.
TABLE 287 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED 312.
TABLE 288 FUJIFILM HOLDINGS CORPORATION: SOLUTION LAUNCHES,.
JANUARY 2023–OCTOBER 2026 313.
TABLE 289 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023–OCTOBER 2026 313.
TABLE 290 GE HEALTHCARE: COMPANY OVERVIEW 316.
TABLE 291 GE HEALTHCARE: SOLUTIONS OFFERED 317.
TABLE 292 GE HEALTHCARE: SOLUTION LAUNCHES & APPROVALS,.
JANUARY 2023–OCTOBER 2026 320.
TABLE 293 GE HEALTHCARE: DEALS, JANUARY 2023–OCTOBER 2026 321.
TABLE 294 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 324.
TABLE 295 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED 325.
TABLE 296 KONINKLIJKE PHILIPS N.V.: SOLUTION LAUNCHES & APPROVALS,.
JANUARY 2023–OCTOBER 2026 327.
TABLE 297 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–OCTOBER 2026 328.
TABLE 298 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023–OCTOBER 2026 329.
TABLE 299 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 331.
TABLE 300 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED 332.
TABLE 301 SIEMENS HEALTHINEERS AG: SOLUTION LAUNCHES,.
JANUARY 2023–OCTOBER 2026 335.
TABLE 302 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023–OCTOBER 2026 335.
TABLE 303 SECTRA AB: COMPANY OVERVIEW 338.
TABLE 304 SECTRA AB: SOLUTIONS OFFERED 339.
TABLE 305 SECTRA AB: SOLUTION LAUNCHES & APPROVALS, JANUARY 2023–OCTOBER 2026 342.
TABLE 306 SECTRA AB: DEALS, JANUARY 2023–OCTOBER 2026 342.
TABLE 307 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2023–OCTOBER 2026 344.
TABLE 308 OPTUM, INC.: COMPANY OVERVIEW 345.
TABLE 309 OPTUM, INC.: SOLUTIONS OFFERED 346.
TABLE 310 OPTUM, INC.: DEALS, JANUARY 2023–OCTOBER 2026 347.
TABLE 311 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 348.
TABLE 312 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED 350.
TABLE 313 CANON MEDICAL SYSTEMS CORPORATION: DEALS,.
JANUARY 2023–OCTOBER 2026 350.
TABLE 314 MERATIVE: COMPANY OVERVIEW 351.
TABLE 315 MERATIVE: SOLUTIONS OFFERED 351.
TABLE 316 MERATIVE: SOLUTION LAUNCHES, JANUARY 2023–OCTOBER 2026 352.
TABLE 317 MERATIVE: DEALS, JANUARY 2023–OCTOBER 2026 352.
TABLE 318 MERATIVE: EXPANSIONS, JANUARY 2023–OCTOBER 2026 353.
TABLE 319 PRO MEDICUS, LTD.: COMPANY OVERVIEW 354.
TABLE 320 PRO MEDICUS, LTD.: SOLUTIONS OFFERED 356.

 

ページTOPに戻る


 

Summary

The global enterprise imaging IT market is projected to reach USD 4.59 billion by 2031, up from USD 2.58 billion in 2026, at a CAGR of 12.2% from 2026 to 2031. Growth in the enterprise imaging IT market is driven by rising diagnostic imaging volumes, the increasing complexity of imaging data, and the need to improve the accessibility, management, and security of medical images across healthcare networks. More than 3.6 billion diagnostic radiology examinations are performed worldwide annually, generating large and continuously expanding volumes of imaging data that require scalable storage, interoperability, and enterprise-wide access. The scale of imaging repositories is further illustrated by Scotland’s national medical imaging archive, which contains approximately 2.47 billion DICOM images across 57.3 million studies, highlighting the growing data-management requirements of healthcare systems. Imaging activity is also increasing in the US, where FDA data indicate that more than 45 million mammography procedures were reported annually as of September 2026, across 9,128 certified facilities and 27,793 accredited units. These trends are increasing demand for enterprise imaging platforms, vendor-neutral archives, cloud-based storage, and interoperable image exchange solutions. However, adoption remains constrained by cybersecurity and integration challenges, as demonstrated by an HHS investigation involving a radiology provider whose PACS server breach exposed medical images of 21,778 individuals.

In 2025, on-premises deployment constituted the largest segment in the enterprise imaging IT market, by deployment mode
By deployment mode, on-premise solutions represented the largest share of the enterprise imaging IT market in 2025. Their leadership stems from hospitals and large healthcare organizations' continued preference for greater control over sensitive medical imaging data, IT infrastructure, security, and system performance. On-premises enterprise imaging platforms enable healthcare providers to keep imaging data within their own infrastructure while integrating with existing PACS, RIS, EHR, and clinical systems. The need to comply with data privacy and healthcare regulations, particularly for organizations with stringent data residency and security requirements, further supports adoption. Moreover, established investments in legacy imaging infrastructure and the high costs and complexity of migrating large imaging archives to the cloud are encouraging healthcare organizations to continue using on-premises solutions. However, increasing demand for scalability, remote image access, reduced infrastructure maintenance, and AI-enabled imaging workflows is expected to support a gradual shift toward cloud-based deployment during the forecast period.

The oncology segment by therapeutic area is expected to register the fastest growth during the forecast period.
By therapeutic area, oncology is expected to be the fastest-growing segment of the enterprise imaging IT market, driven by the growing use of medical imaging for cancer screening, diagnosis, staging, treatment planning, and monitoring. The rising prevalence of cancer and demand for advanced imaging modalities, including CT, MRI, PET, and molecular imaging, are generating substantial volumes of oncology-related imaging data. Enterprise imaging platforms enable healthcare organizations to centrally store, access, share, and analyze these images across multidisciplinary oncology teams and care settings. Furthermore, the growing adoption of AI-enabled imaging for tumor detection, lesion characterization, treatment response assessment, and workflow prioritization is supporting demand for integrated imaging solutions. The expansion of precision oncology and multidisciplinary cancer care is further increasing the need for interoperable platforms that connect imaging data with EHRs, oncology information systems, and other clinical applications.

Asia Pacific to witness the highest growth rate during the forecast period.
The Asia Pacific region is projected to post the highest growth rate in the enterprise imaging IT market over the forecast period, supported by rapid healthcare digitalization, expanding diagnostic imaging infrastructure, and growing adoption of cloud-based and AI-enabled imaging solutions. China is accelerating the development of regional medical imaging infrastructure, with the National Health Commission reporting that medical imaging centers now cover more than 70% of township health centers, enabling greater sharing of diagnostic resources between primary and higher-level facilities. In August 2025, China's National Healthcare Security Administration reported that 22 provinces had deployed software for a national medical imaging cloud-sharing pathway, with 17 provinces enabling cross-provincial access to imaging data and more than 18.48 million imaging index records aggregated nationally. India is also expanding its digital healthcare infrastructure; as of July 2026, more than 948.7 million ABHA accounts and 536,000 healthcare facilities had been registered under the Ayushman Bharat Digital Mission, strengthening the digital ecosystem required for interoperable healthcare data exchange. Furthermore, China is promoting AI-enabled medical imaging, including intelligent image-assisted diagnosis and report generation, while Japan and other technologically advanced Asia Pacific markets continue to strengthen enterprise imaging and PACS infrastructure. These developments, alongside rising imaging volumes, expanding multi-site healthcare networks, growing teleradiology adoption, and demand for interoperable image-sharing platforms, are expected to accelerate adoption of enterprise imaging IT solutions across Asia Pacific.

The breakdown of primary participants is as mentioned below:
- By Company Type - Tier 1: 34%, Tier 2: 46%, and Tier 3: 20%
- By Designation - C-level: 35%, Director-level: 25%, and Others: 40%
- By Region - North America: 30%, Europe: 45%, Asia Pacific: 20%, Middle East & Africa: 3%, Latin America: 2%

Key Players in the Enterprise Imaging IT Market
The key players functioning in the enterprise imaging IT market include Agfa-Gevaert Group. (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), among others.

Research Coverage:
The scope of the report covers detailed information on the major factors, such as drivers, restraints, challenges, and opportunities, that influence the growth of the enterprise imaging IT market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, and agreements; new product and service launches; mergers and acquisitions; and recent developments associated with the enterprise imaging IT market. The report also covers a competitive analysis of upcoming startups in the enterprise imaging IT market ecosystem.

Reasons to Buy the Report
This report will help established firms and new or smaller entrants gauge the market's pulse, which, in turn, would help them gain a greater share of the market. Firms purchasing the report could use one or more of the strategies mentioned below to strengthen their positions in the market.

This report provides insights on:
- Analysis of key drivers (growing volume of medical imaging procedures, increasing demand for scalable and cost-effective solutions, increasing adoption of cloud-based enterprise imaging solutions), restraints (data security and privacy concerns, lack of skilled professionals for deployment and interpretation), opportunities (growth of vendor-neutral archives (VNA) and interoperability, increasing adoption of AI-enabled imaging and advanced visualization), and challenges (limited adoption in developing regions, high upfront integration and deployment costs) influencing the growth of the enterprise imaging IT market.
- Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and new product launches in the enterprise imaging IT market.
- Market Development: Comprehensive information on the lucrative emerging markets, function, modality, application, offering, deployment mode, therapeutic area, end-users, and regions.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the enterprise imaging IT market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the enterprise imaging IT market such as Agfa-Gevaert Group. (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), among others.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.3 MARKET SCOPE 34
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 34
1.3.2 INCLUSIONS & EXCLUSIONS 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY 37
1.6 STAKEHOLDERS 37
1.7 SUMMARY OF CHANGES 38

2 EXECUTIVE SUMMARY 39
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 39
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 41
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 42
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 43
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 44

3 PREMIUM INSIGHTS 45
3.1 ENTERPRISE IMAGING IT MARKET OVERVIEW 45
3.2 ENTERPRISE IMAGING IT MARKET, BY APPLICATION & REGION 46
3.3 ENTERPRISE IMAGING IT MARKET: GEOGRAPHIC SNAPSHOT 47

4 MARKET OVERVIEW 48
4.1 INTRODUCTION 48
4.2 MARKET DYNAMICS 48
4.2.1 DRIVERS 50
4.2.1.1 Increased demand for scalable and cost-effective solutions 50
4.2.1.2 Advancements in AI and imaging technologies 50
4.2.1.3 Growing volume of medical imaging procedures 51
4.2.1.4 Growing need for remote access and collaborative care 52
4.2.1.5 Government initiatives and favorable policies 52
4.2.2 RESTRAINTS 53
4.2.2.1 Data security and privacy concerns 53
4.2.2.2 Lack of skilled professionals for deployment and interpretation 56
4.2.3 OPPORTUNITIES 57
4.2.3.1 Expansion into emerging markets 57
4.2.3.2 Multi modality and advanced visualization 58
4.2.3.3 Partnerships with AI and analytics providers 58
4.2.3.4 Value-based care and population health management 59
4.2.3.5 Cloud native and edge computing innovations 60
4.2.4 CHALLENGES 60
4.2.4.1 Interoperability with legacy and vendor‑specific systems 60
4.2.4.2 High upfront integration and deployment costs 60
4.2.4.3 Workflow disruption and user adoption 61
4.3 UNMET NEEDS AND WHITE SPACES 61
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 63
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65

5 INDUSTRY TRENDS 67
5.1 PORTER’S FIVE FORCES ANALYSIS 67
5.1.1 BARGAINING POWER OF SUPPLIERS 68
5.1.2 BARGAINING POWER OF BUYERS 68
5.1.3 THREAT OF SUBSTITUTES 68
5.1.4 THREAT OF NEW ENTRANTS 68
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.2 MACROECONOMIC INDICATORS 69
5.2.1 INTRODUCTION 69
5.2.2 GDP TRENDS AND FORECAST 70
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 70
5.3 VALUE CHAIN ANALYSIS 71
5.4 ECOSYSTEM ANALYSIS 73
5.5 PRICING ANALYSIS 75
5.5.1 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT MARKET,
BY OFFERING (2025) 76
5.5.2 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT SOLUTIONS,
BY REGION (2025) 77
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 78
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 79
5.8 INVESTMENT AND FUNDING SCENARIO 79
5.9 CASE STUDY ANALYSIS 80
5.10 IMPACT OF 2025 US TARIFFS ON ENTERPRISE IMAGING IT MARKET 82
5.10.1 INTRODUCTION 83
5.10.2 KEY TARIFF RATES 83
5.10.3 PRICE IMPACT ANALYSIS 84
5.10.3.1 Increased costs of hardware components 84
5.10.3.2 Software & licensing inflation 84
5.10.3.3 Supply chain disruption 84
5.10.4 IMPACT ON COUNTRY/REGION 84
5.10.4.1 US 84
5.10.4.2 Europe 85
5.10.4.3 Asia Pacific 85
5.10.5 IMPACT ON END USERS 85
5.10.5.1 Hospitals (large, mid-sized, and academic medical centers) 85
5.10.5.2 Diagnostic centers (independent and chain-based) 86
5.10.5.3 Teleradiology providers 86

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 87
6.1 KEY EMERGING TECHNOLOGIES 87
6.1.1 IMAGING ANALYTICS PLATFORMS 87
6.1.2 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 88
6.1.3 MULTI MODALITY FUSION & CO REGISTRATION ENGINES 88
6.1.4 ZERO FOOTPRINT VIEWERS 88
6.1.5 MOBILE ENTERPRISE IMAGING AND WORKFLOW BOTS 89
6.2 COMPLEMENTARY TECHNOLOGIES 89
6.2.1 RADIOLOGY INFORMATION SYSTEMS (RIS) 89
6.2.2 ELECTRONIC HEALTH RECORD (EHR/EMR) INTEGRATION 90
6.3 ADJACENT TECHNOLOGIES 90
6.3.1 CLOUD COMPUTING & STORAGE 90
6.3.2 BLOCKCHAIN & DISTRIBUTED LEDGER TECHNOLOGY 91
6.4 TECHNOLOGY/PRODUCT ROADMAP 91
6.5 PATENT ANALYSIS 92
6.5.1 PATENT PUBLICATION TRENDS FOR ENTERPRISE IMAGING IT MARKET 92
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 93
6.6 FUTURE APPLICATIONS 96
6.6.1 AI-DRIVEN IMAGE ANALYSIS & CLINICAL DECISION SUPPORT 96
6.6.2 CLOUD-BASED IMAGING & ENTERPRISE-WIDE DATA MANAGEMENT 97
6.6.3 MULTIDISCIPLINARY IMAGING & INTEROPERABLE CLINICAL WORKFLOWS 97
6.6.4 ADVANCED VISUALIZATION, DIGITAL PATHOLOGY, AND PRECISION HEALTHCARE 97
6.6.5 AUTOMATED IMAGING WORKFLOWS & INTELLIGENT DATA GOVERNANCE 98
6.7 IMPACT OF GENERATIVE AI ON ENTERPRISE IMAGING IT MARKET 98
6.7.1 INTRODUCTION 98
6.7.2 TOP USE CASES & MARKET POTENTIAL 98
6.7.2.1 Key use cases 99
6.7.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 100
6.7.3.1 Case Study 1: Enabling interoperability and scalability across enterprise imaging networks with Dicom Systems’ Unifier Platform 100
6.7.3.2 Case Study 2: San Gerardo Hospital transforms radiology with Agfa HealthCare’s Enterprise Imaging 101
6.7.4 INTERCONNECTED & ADJACENT MARKETS 101
6.7.4.1 Vendor-neutral Archive (VNA) & PACS market 102
6.7.4.2 Medical image analysis software market 102
6.7.4.3 Healthcare IT market 102
6.7.5 USER READINESS & IMPACT ASSESSMENT 102
6.7.5.1 User readiness 102
6.7.5.1.1 User A: Hospitals 102
6.7.5.1.2 User B: Diagnostic centers 103
6.7.5.2 Impact assessment 103
6.7.5.2.1 User A: Hospitals 103
6.7.5.2.1.1 Implementation 103
6.7.5.2.1.2 Impact 103
6.7.5.2.2 User B: Diagnostic centers 104
6.7.5.2.2.1 Implementation 104
6.7.5.2.2.2 Impact 104

7 REGULATORY LANDSCAPE 105
7.1 REGIONAL REGULATIONS AND COMPLIANCE 105
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 105
7.1.2 REGULATORY FRAMEWORK 109
7.1.2.1 North America 109
7.1.2.2 Europe 110
7.1.2.3 Asia Pacific 111
7.1.2.4 Latin America 112
7.1.2.5 Middle East & Africa 112
7.1.3 INDUSTRY STANDARDS 112

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 114
8.1 INTRODUCTION 114
8.2 DECISION-MAKING PROCESS 114
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 115
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 115
8.3.2 BUYING CRITERIA 116
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 117
8.5 UNMET NEEDS FROM VARIOUS END USERS 118
8.5.1 UNMET NEEDS 118
8.5.2 END USER EXPECTATIONS 120
8.6 MARKET PROFITABILITY 121

9 ENTERPRISE IMAGING IT MARKET, BY FUNCTION 122
9.1 INTRODUCTION 123
9.2 VENDOR-NEUTRAL ARCHIVES (VNA) 123
9.2.1 ADVANCING SEAMLESS INFORMATION EXCHANGE THROUGH VNA SOLUTIONS TO BOOST MARKET GROWTH 123
9.3 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) 125
9.3.1 GROWING INTEGRATION OF AI WITHIN PACS FOR OPTIMIZED RADIOLOGY WORKFLOWS TO SUPPORT MARKET GROWTH 125
9.4 IMAGE EXCHANGE 126
9.4.1 GROWING POPULARITY OF INTEROPERABLE IMAGING NETWORKS FOR PATIENT-CENTERED DATA SHARING TO DRIVE GROWTH 126
9.5 UNIVERSAL VIEWERS 128
9.5.1 GROWING UNIVERSAL VIEWER DEPLOYMENT FOR MULTI-DISCIPLINARY IMAGING TO FUEL MARKET 128
9.6 WORKFLOW ORCHESTRATION 129
9.6.1 AI-POWERED IMAGING WORKFLOW AUTOMATION AND CROSS-MODALITY COORDINATION TO PROPEL MARKET 129
9.7 ANALYTICS 130
9.7.1 GROWING NEED FOR ANALYTICS PLATFORMS FOR VALUE-BASED IMAGING AND OPERATIONAL OPTIMIZATION TO DRIVE MARKET 130
9.8 OTHER FUNCTIONS 132

10 ENTERPRISE IMAGING IT MARKET, BY MODALITY 133
10.1 INTRODUCTION 134
10.2 X-RAY 134
10.2.1 GROWTH IN ENTERPRISE IMAGING THROUGH AI-ENABLED X-RAY SOLUTIONS TO BOOST MARKET 134
10.3 MAGNETIC RESONANCE IMAGING (MRI) 136
10.3.1 EXPANDING MRI ENTERPRISE IT TO MEET RISING NEUROLOGICAL IMAGING DEMANDS TO SUPPORT MARKET GROWTH 136
10.4 COMPUTED TOMOGRAPHY (CT) 137
10.4.1 REGULATORY AND VALUE-BASED INCENTIVES TO FUEL CT IMAGING IT ADOPTION 137
10.5 ULTRASOUND 138
10.5.1 AI-POWERED ULTRASOUND AND POCUS TO ACCELERATE ENTERPRISE IMAGING TRANSFORMATION 138
10.6 NUCLEAR IMAGING 139
10.6.1 POSITRON EMISSION TOMOGRAPHY (PET) 141
10.6.1.1 Rising PET scan volumes to drive demand for scalable, intelligent Imaging IT 141
10.6.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 142
10.6.2.1 Driving diagnostic accuracy with automated SPECT workflows to contribute to growth 142
10.7 ENDOSCOPY 143
10.7.1 ENABLING REAL-TIME ENDOSCOPIC INSIGHTS THROUGH CLOUD-NATIVE VIDEO ORCHESTRATION TO DRIVE MARKET 143
10.8 MAMMOGRAPHY 144
10.8.1 NEED FOR ENTERPRISE IMAGING SOLUTIONS FOR HIGH-VOLUME, HIGH-RESOLUTION MAMMOGRAPHY WORKFLOWS TO FUEL GROWTH 144
10.9 FLUOROSCOPY 145
10.9.1 STRATEGIC CLOUD-NATIVE IMAGING FOR ADVANCED FLUOROSCOPY USE CASES TO AID WITH GROWTH 145
10.10 ECHOCARDIOGRAPHY 146
10.10.1 ABILITY TO ENHANCE FLUOROSCOPY IMAGING EFFICIENCY WITH AI-INTEGRATED ENTERPRISE IT SOLUTIONS TO BOOST MARKET 146
10.11 OTHER MODALITIES 147

11 ENTERPRISE IMAGING IT MARKET, BY APPLICATION 149
11.1 INTRODUCTION 150
11.2 DIAGNOSTICS 150
11.2.1 AI-ENABLED QUANTIFICATION AND INTEGRATED THERANOSTIC WORKFLOWS TO DRIVE DIAGNOSTIC IMAGING TRANSFORMATION 150
11.3 THERAPEUTICS 151
11.3.1 ADVANTAGES SUCH AS MULTIMODAL TREATMENT INTEGRATION TO OPTIMIZE ENTERPRISE IMAGING FOR THERAPEUTIC WORKFLOWS 151
11.4 CLINICAL RESEARCH 152
11.4.1 AI-ENABLED QUANTIFICATION AND RAPID-RESPONSE IMAGING WORKFLOWS TO ACCELERATE CLINICAL RESEARCH 152

12 ENTERPRISE IMAGING IT MARKET, BY OFFERING 154
12.1 INTRODUCTION 155
12.2 SOFTWARE 155
12.2.1 ADVANCING UNIFIED IMAGING ECOSYSTEMS THROUGH CLOUD-NATIVE SOFTWARE TO BOOST MARKET GROWTH 155
12.3 SERVICES 156
12.3.1 ADVANTAGES SUCH AS EXPERT SERVICES, CLOUD MIGRATION, AND WORKFLOW OPTIMIZATION TO SUPPORT MARKET GROWTH 156

13 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE 158
13.1 INTRODUCTION 159
13.2 ON-PREMISE SOLUTIONS 159
13.2.1 GROWING NEED FOR IMAGING PERFORMANCE AND DATA CONTROL THROUGH ON-PREMISE DEPLOYMENT TO SUPPORT MARKET GROWTH 159
13.3 CLOUD-BASED SOLUTIONS 160
13.3.1 RISING NEED FOR COST-EFFICIENT, SCALABLE INFRASTRUCTURE TO DRIVE DEMAND FOR CLOUD-BASED DEPLOYMENT 160
13.4 HYBRID SOLUTIONS 161
13.4.1 ABILITY TO BRIDGE DATA CONTROL AND CLOUD INNOVATION THROUGH HYBRID DEPLOYMENT TO BOOST GROWTH 161

14 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA 163
14.1 INTRODUCTION 164
14.2 NEUROLOGY 164
14.2.1 INTEGRATION OF AI-DRIVEN MULTIMODAL NEUROIMAGING FOR PERSONALIZED NEUROLOGICAL CARE TO BOOST MARKET 164
14.3 CARDIOLOGY 166
14.3.1 CLOUD-ENABLED, AI-DRIVEN ENTERPRISE IMAGING PLATFORMS TO ACCELERATE ADVANCED CARDIAC DIAGNOSTICS 166
14.4 ONCOLOGY 167
14.4.1 AI-DRIVEN, MULTIMODAL ENTERPRISE IMAGING PLATFORMS TO ADVANCE PRECISION ONCOLOGY 167
14.5 ORTHOPEDICS 168
14.5.1 ABILITY OF AI-ENABLED ENTERPRISE IMAGING PLATFORMS TO TRANSFORM ORTHOPEDIC CARE TO DRIVE DEMAND 168
14.6 OTHER THERAPEUTIC AREAS 169

15 ENTERPRISE IMAGING IT MARKET, BY END USER 170
15.1 INTRODUCTION 171
15.2 HOSPITALS 171
15.2.1 HOSPITALS TO DRIVE DEMAND FOR UNIFIED IMAGING INFRASTRUCTURE TO SUPPORT INTEGRATED CARE DELIVERY 171
15.3 DIAGNOSTIC CENTERS 173
15.3.1 GROWING ADOPTION OF ENTERPRISE IMAGING IT TO ENHANCE WORKFLOW EFFICIENCY IN DIAGNOSTIC CENTERS TO BOOST MARKET 173
15.4 CLINICS & OUTPATIENT SETTINGS 174
15.4.1 GROWING POPULARITY OF LIGHTWEIGHT ENTERPRISE IMAGING IT TO BOOST EFFICIENCY AND PATIENT THROUGHPUT TO FUEL GROWTH 174
15.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 175
15.5.1 GROWING USE OF ENTERPRISE IMAGING IT FOR TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT TO DRIVE MARKET 175
15.6 MEDTECH COMPANIES 176
15.6.1 ABILITY OF ENTERPRISE IMAGING IT TO ACCELERATE DEVICE INNOVATION AND CLINICAL INTEGRATION TO FUEL ADOPTION 176
15.7 RESEARCH & ACADEMIC INSTITUTES 177
15.7.1 GROWING NEED TO POWER DATA-DRIVEN DISCOVERY AND COLLABORATION TO SUPPORT MARKET GROWTH 177
15.8 OTHER END USERS 178

16 ENTERPRISE IMAGING IT MARKET, BY REGION 180
16.1 INTRODUCTION 181
16.2 NORTH AMERICA 181
16.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 182
16.2.2 US 187
16.2.2.1 AI integration, cloud adoption, and regulatory push to accelerate enterprise imaging IT transformation in US 187
16.2.3 CANADA 192
16.2.3.1 Provincial interoperability mandates and cloud-enabled AI to drive growth in Canada's imaging IT market 192
16.3 EUROPE 196
16.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 196
16.3.2 GERMANY 201
16.3.2.1 Hospital modernization and ePA adoption to propel Germany’s enterprise imaging IT growth 201
16.3.3 UK 205
16.3.3.1 NHS push for AI-driven imaging and cloud integration to fuel market growth 205
16.3.4 FRANCE 209
16.3.4.1 Accelerated cloud-native, interoperable imaging platforms with focus on data sovereignty to drive market 209
16.3.5 ITALY 213
16.3.5.1 Growing VNA and teleradiology adoption in Italy to modernize imaging infrastructure 213
16.3.6 SPAIN 217
16.3.6.1 Spain to scale cloud imaging and VNA for regional collaboration 217
16.3.7 REST OF EUROPE 221
16.4 ASIA PACIFIC 225
16.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 225
16.4.2 CHINA 231
16.4.2.1 AI diagnostic approvals to accelerate market growth 231
16.4.3 JAPAN 235
16.4.3.1 Aging demographics to drive demand for scalable imaging solutions 235
16.4.4 INDIA 239
16.4.4.1 Government-led digitization to fuel imaging infrastructure expansion 239
16.4.5 REST OF ASIA PACIFIC 243
16.5 LATIN AMERICA 247
16.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 247
16.5.2 BRAZIL 252
16.5.2.1 Government investments to accelerate public health digitization drives 252
16.5.3 MEXICO 256
16.5.3.1 Accelerating imaging modernization through nationwide digital integration in Mexico to boost market 256
16.5.4 REST OF LATIN AMERICA 260
16.6 MIDDLE EAST & AFRICA 264
16.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 265
16.6.2 GCC COUNTRIES 269
16.6.2.1 Enterprise imaging adoption accelerates across GCC amid workforce gaps and digital health push to support growth 269
16.6.3 REST OF MIDDLE EAST & AFRICA 273

17 COMPETITIVE LANDSCAPE 278
17.1 OVERVIEW 278
17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023–2026 278
17.3 REVENUE ANALYSIS, 2021–2025 281
17.4 MARKET SHARE ANALYSIS, 2025 282
17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 286
17.5.1 STARS 286
17.5.2 EMERGING LEADERS 286
17.5.3 PERVASIVE PLAYERS 286
17.5.4 PARTICIPANTS 286
17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 288
17.5.5.1 Company footprint 288
17.5.5.2 Region footprint 289
17.5.5.3 Function footprint 290
17.5.5.4 Application footprint 291
17.5.5.5 Therapeutic footprint 292
17.5.5.6 Deployment footprint 293
17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 294
17.6.1 PROGRESSIVE COMPANIES 294
17.6.2 RESPONSIVE COMPANIES 294
17.6.3 DYNAMIC COMPANIES 294
17.6.4 STARTING BLOCKS 294
17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 296
17.6.5.1 Detailed list of key startups/SMEs 296
17.6.5.2 Competitive benchmarking of startups/SMEs 296
17.7 VALUATION & FINANCIAL METRICS 298
17.7.1 FINANCIAL METRICS 298
17.7.2 COMPANY VALUATION 298
17.8 BRAND/SOFTWARE COMPARISON 299
17.9 COMPETITIVE SCENARIO 300
17.9.1 SOLUTION LAUNCHES & ENHANCEMENT 300
17.9.2 DEALS 301
17.9.3 EXPANSIONS 302
17.9.4 OTHER DEVELOPMENTS 303

18 COMPANY PROFILES 304
18.1 KEY PLAYERS 304
18.1.1 AGFA-GEVAERT GROUP 304
18.1.1.1 Business overview 304
18.1.1.2 Solutions offered 305
18.1.1.3 Recent developments 307
18.1.1.3.1 Deals 307
18.1.1.4 MnM view 309
18.1.1.4.1 Key strengths 309
18.1.1.4.2 Strategic choices 309
18.1.1.4.3 Weaknesses & competitive threats 309
18.1.2 FUJIFILM HOLDINGS CORPORATION 310
18.1.2.1 Business overview 310
18.1.2.2 Solutions offered 312
18.1.2.3 Recent developments 313
18.1.2.3.1 Solution launches 313
18.1.2.3.2 Deals 313
18.1.2.4 MnM view 315
18.1.2.4.1 Key strengths 315
18.1.2.4.2 Strategic choices 315
18.1.2.4.3 Weaknesses & competitive threats 315
18.1.3 GE HEALTHCARE 316
18.1.3.1 Business overview 316
18.1.3.2 Solutions offered 317
18.1.3.3 Recent developments 320
18.1.3.3.1 Solution launches & approvals 320
18.1.3.3.2 Deals 321
18.1.3.4 MnM view 323
18.1.3.4.1 Key strengths 323
18.1.3.4.2 Strategic choices 323
18.1.3.4.3 Weaknesses & competitive threats 323
18.1.4 KONINKLIJKE PHILIPS N.V. 324
18.1.4.1 Business overview 324
18.1.4.2 Solutions offered 325
18.1.4.3 Recent developments 327
18.1.4.3.1 Solution launches & approvals 327
18.1.4.3.2 Deals 328
18.1.4.3.3 Expansions 329
18.1.4.4 MnM view 329
18.1.4.4.1 Key strengths 329
18.1.4.4.2 Strategic choices 330
18.1.4.4.3 Weaknesses & competitive threats 330
18.1.5 SIEMENS HEALTHINEERS AG 331
18.1.5.1 Business overview 331
18.1.5.2 Solutions offered 332
18.1.5.3 Recent developments 335
18.1.5.3.1 Solution launches 335
18.1.5.3.2 Deals 335
18.1.5.4 MnM view 336
18.1.5.4.1 Key strengths 336
18.1.5.4.2 Strategic choices 337
18.1.5.4.3 Weaknesses & competitive threats 337
18.1.6 SECTRA AB 338
18.1.6.1 Business overview 338
18.1.6.2 Solutions offered 339
18.1.6.3 Recent developments 342
18.1.6.3.1 Solution launches & approvals 342
18.1.6.3.2 Deals 342
18.1.6.3.3 Other developments 344
18.1.7 OPTUM, INC. 345
18.1.7.1 Business overview 345
18.1.7.2 Solutions offered 346
18.1.7.3 Recent developments 347
18.1.7.3.1 Deals 347
18.1.8 CANON MEDICAL SYSTEMS CORPORATION 348
18.1.8.1 Business overview 348
18.1.8.2 Solutions offered 350
18.1.8.3 Recent developments 350
18.1.8.3.1 Deals 350
18.1.9 MERATIVE 351
18.1.9.1 Business overview 351
18.1.9.2 Solutions offered 351
18.1.9.3 Recent developments 352
18.1.9.3.1 Solution launches 352
18.1.9.3.2 Deals 352
18.1.9.3.3 Expansions 353
18.1.10 PRO MEDICUS, LTD. 354
18.1.10.1 Business overview 354
18.1.10.2 Solutions offered 356
18.1.10.3 Recent developments 357
18.1.10.3.1 Solution launches 357
18.1.10.3.2 Deals 357
18.1.11 HYLAND 358
18.1.11.1 Business overview 358
18.1.11.2 Solutions offered 358
18.1.11.3 Recent developments 360
18.1.11.3.1 Solution launches 360
18.1.11.3.2 Deals 360
18.1.11.3.3 Expansions 361
18.1.12 INFINITT HEALTHCARE CO., LTD. 362
18.1.12.1 Business overview 362
18.1.12.2 Recent developments 363
18.1.12.2.1 Solution launches & approvals 363
18.1.12.2.2 Deals 363
18.1.13 NOVARAD 364
18.1.13.1 Business overview 364
18.1.13.2 Solutions offered 364
18.1.13.3 Recent developments 366
18.1.13.3.1 Solution launches 366
18.1.13.3.2 Deals 366
18.1.14 MACH7 TECHNOLOGIES 367
18.1.14.1 Business overview 367
18.1.14.2 Solutions offered 369
18.1.14.3 Recent developments 369
18.1.14.3.1 Solution launches 369
18.1.14.3.2 Deals 370
18.1.15 HERMES MEDICAL SOLUTIONS 371
18.1.15.1 Business overview 371
18.1.15.2 Solutions offered 371
18.1.15.3 Recent developments 373
18.1.15.3.1 Solution launches, approvals, and enhancements 373
18.1.15.3.2 Deals 374
18.1.16 KONICA MINOLTA, INC. 375
18.1.16.1 Business overview 375
18.1.16.2 Solutions offered 376
18.1.16.3 Recent developments 379
18.1.16.3.1 Solution launches & enhancements 379
18.1.16.3.2 Deals 380
18.1.16.3.3 Expansions 381
18.1.16.3.4 Other developments 381
18.1.17 BRIDGEHEAD SOFTWARE LTD. 382
18.1.17.1 Business overview 382
18.1.17.2 Solutions offered 382
18.1.17.3 Recent developments 383
18.1.17.3.1 Deals 383
18.1.18 SCIMAGE, INC. 384
18.1.18.1 Business overview 384
18.1.18.2 Solutions offered 384
18.1.18.3 Recent developments 386
18.1.18.3.1 Solution launches 386
18.1.18.3.2 Deals 386
18.1.19 RAMSOFT INC. 387
18.1.19.1 Business overview 387
18.1.19.2 Solutions offered 387
18.1.19.3 Recent developments 388
18.1.19.3.1 Solution launches & enhancements 388
18.1.19.3.2 Deals 389
18.1.20 DICOM SYSTEMS, INC. 391
18.1.20.1 Business overview 391
18.1.20.2 Solutions offered 392
18.1.20.3 Recent developments 392
18.1.20.3.1 Deals 392
18.2 OTHER PLAYERS 393
18.2.1 POSTDICOM B.V. 393
18.2.2 QAELUM 394
18.2.3 ADVAHEALTH SOLUTIONS 395
18.2.4 PAXERAHEALTH 396
18.2.5 RAD AI 397

19 RESEARCH METHODOLOGY 398
19.1 RESEARCH DATA 398
19.1.1 SECONDARY DATA 399
19.1.1.1 Key data from secondary sources 399
19.1.2 PRIMARY DATA 400
19.1.2.1 Key data from primary sources 401
19.1.2.2 Breakdown of primary sources 402
19.2 RESEARCH APPROACH 403
19.3 MARKET SIZE ESTIMATION 404
19.4 MARKET BREAKDOWN & DATA TRIANGULATION 408
19.5 MARKET SHARE ESTIMATION 409
19.6 STUDY ASSUMPTIONS 410
19.7 RESEARCH LIMITATIONS 410
19.7.1 METHODOLOGY-RELATED LIMITATIONS 410
19.7.2 SCOPE-RELATED LIMITATIONS 411
19.8 RISK ASSESSMENT 411

20 APPENDIX 412
20.1 DISCUSSION GUIDE 412
20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 417
20.3 CUSTOMIZATION OPTIONS 419
20.4 RELATED REPORTS 419
20.5 AUTHOR DETAILS 420

ページTOPに戻る



List of Tables/Graphs

FIGURE 1 ENTERPRISE IMAGING IT MARKET SEGMENTATION & REGIONAL SCOPE 34.
FIGURE 2 MARKET SCENARIO 40.
FIGURE 3 GLOBAL ENTERPRISE IMAGING IT MARKET, 2024–2031 40.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET, 2023–2026 41.
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF ENTERPRISE IMAGING IT MARKET 42.
FIGURE 6 HIGH-GROWTH SEGMENTS IN ENTERPRISE IMAGING IT MARKET, 2026–2031 43.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ENTERPRISE IMAGING IT MARKET DURING FORECAST PERIOD 44.
FIGURE 8 RISING IN IMAGING VOLUMES TO DRIVE GROWTH IN ENTERPRISE.
IMAGING IT MARKET 45.
FIGURE 9 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE.
IN NORTH AMERICA IN 2025 46.
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 47.
FIGURE 11 ENTERPRISE IMAGING IT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,.
AND CHALLENGES 48.
FIGURE 12 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2026 54.
FIGURE 13 US: MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR, 2008–2028 54.
FIGURE 14 ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS 67.
FIGURE 15 ENTERPRISE IMAGING IT MARKET: VALUE CHAIN ANALYSIS 72.
FIGURE 16 ENTERPRISE IMAGING IT MARKET: ECOSYSTEM ANALYSIS 74.
FIGURE 17 REVENUE SHIFT IN ENTERPRISE IMAGING IT MARKET 79.
FIGURE 18 RECENT FUNDING OF PLAYERS IN ENTERPRISE IMAGING IT MARKET 80.
FIGURE 19 PATENT PUBLICATION TRENDS IN ENTERPRISE IMAGING IT MARKET, 2015–2026 93.
FIGURE 20 JURISDICTION AND TOP APPLICANT ANALYSIS FOR ENTERPRISE IMAGING.
IT MARKET 93.
FIGURE 21 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENTERPRISE IMAGING IT MARKET (JANUARY 2015–OCTOBER 2026) 94.
FIGURE 22 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING ENTERPRISE.
IMAGING IT ACROSS INDUSTRIES 99.
FIGURE 23 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 101.
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 115.
FIGURE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 116.
FIGURE 26 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET SNAPSHOT 182.
FIGURE 27 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET SNAPSHOT 226.
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET,.
2021–2025 (USD MILLION) 282.
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 283.
FIGURE 30 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 287.
FIGURE 31 ENTERPRISE IMAGING IT MARKET: COMPANY FOOTPRINT 288.
FIGURE 32 ENTERPRISE IMAGING IT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 295.
FIGURE 33 EV/EBITDA OF KEY VENDORS 298.
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA.
OF KEY VENDORS 298.
FIGURE 35 ENTERPRISE IMAGING IT MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 299.
FIGURE 36 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2025) 305.
FIGURE 37 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 311.
FIGURE 38 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 317.
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 325.
FIGURE 40 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 332.
FIGURE 41 SECTRA AB: COMPANY SNAPSHOT (2025) 339.
FIGURE 42 OPTUM, INC.: COMPANY SNAPSHOT (2025) 345.
FIGURE 43 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2025) 349.
FIGURE 44 PRO MEDICUS, LTD.: COMPANY SNAPSHOT (2025) 355.
FIGURE 45 MACH7 TECHNOLOGIES: COMPANY SNAPSHOT (2024) 368.
FIGURE 46 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2026) 376.
FIGURE 47 RESEARCH DESIGN 398.
FIGURE 48 PRIMARY SOURCES 400.
FIGURE 49 INSIGHTS FROM INDUSTRY EXPERTS 402.
FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,.
AND REGION 402.
FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 403.
FIGURE 52 BOTTOM-UP APPROACH 404.
FIGURE 53 TOP-DOWN APPROACH 405.
FIGURE 54 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031) 406.
FIGURE 55 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 407.
FIGURE 56 DATA TRIANGULATION METHODOLOGY 409.
TABLE 1 USD EXCHANGE RATES 37.
TABLE 2 ENTERPRISE IMAGING IT MARKET: IMPACT ANALYSIS 49.
TABLE 3 US: TOP 30 HEALTHCARE DATA BREACHES, 2011–2026 55.
TABLE 4 ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS 68.
TABLE 5 ENTERPRISE IMAGING IT MARKET: ROLE IN ECOSYSTEM 74.
TABLE 6 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT MARKET, BY OFFERING (2025) 76.
TABLE 7 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT SOLUTIONS, BY REGION (2025) 77.
TABLE 8 ENTERPRISE IMAGING IT MARKET: KEY CONFERENCES & EVENTS, 2026–2027 78.
TABLE 9 CASE STUDY 1: ENHANCING IMAGING EFFICIENCY & SECURITY WITH SECTRA’S AUTOMATED MULTIMEDIA WORKFLOW 80.
TABLE 10 CASE STUDY 2: ENTERPRISE IMAGING CONSOLIDATION AT PIEDMONT HEALTHCARE WITH HYLAND VNA 81.
TABLE 11 CASE STUDY 3: ENTERPRISE-WIDE IMAGING UNIFICATION WITH GE’S EDISON DATALOGUE AT A LEADING MEDICAL CENTER 81.
TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES 83.
TABLE 13 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR ENTERPRISE IMAGING IT MARKET 94.
TABLE 14 ENTERPRISE IMAGING IT MARKET: LIST OF PATENTS/PATENT APPLICATIONS 95.
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 105.
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106.
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 107.
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 108.
TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 108.
TABLE 20 REGULATORY SCENARIO OF NORTH AMERICA 109.
TABLE 21 REGULATORY SCENARIO OF EUROPE 110.
TABLE 22 REGULATORY SCENARIO OF ASIA PACIFIC 111.
TABLE 23 REGULATORY SCENARIO OF LATIN AMERICA 112.
TABLE 24 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 112.
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF.
TOP THREE END USERS (%) 116.
TABLE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS 117.
TABLE 27 UNMET NEEDS IN ENTERPRISE IMAGING IT MARKET 119.
TABLE 28 END USER EXPECTATIONS IN ENTERPRISE IMAGING IT MARKET 120.
TABLE 29 ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 123.
TABLE 30 VENDOR-NEUTRAL ARCHIVES (VNA) OFFERED BY KEY MARKET PLAYERS 124.
TABLE 31 ENTERPRISE IMAGING IT MARKET FOR VENDOR-NEUTRAL ARCHIVES (VNA),.
BY REGION, 2024–2031 (USD MILLION) 124.
TABLE 32 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) OFFERED.
BY KEY MARKET PLAYERS 126.
TABLE 33 ENTERPRISE IMAGING IT MARKET FOR PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY REGION, 2024–2031 (USD MILLION) 126.
TABLE 34 IMAGE EXCHANGE SOLUTIONS OFFERED BY KEY MARKET PLAYERS 127.
TABLE 35 ENTERPRISE IMAGING IT MARKET FOR IMAGE EXCHANGE,.
BY REGION, 2024–2031 (USD MILLION) 127.
TABLE 36 UNIVERSAL VIEWERS OFFERED BY KEY MARKET PLAYERS 128.
TABLE 37 ENTERPRISE IMAGING IT MARKET FOR UNIVERSAL VIEWERS,.
BY REGION, 2024–2031 (USD MILLION) 129.
TABLE 38 WORKFLOW ORCHESTRATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 130.
TABLE 39 ENTERPRISE IMAGING IT MARKET FOR WORKFLOW ORCHESTRATION,.
BY REGION, 2024–2031 (USD MILLION) 130.
TABLE 40 ANALYTICS SOLUTIONS OFFERED BY KEY MARKET PLAYERS 131.
TABLE 41 ENTERPRISE IMAGING IT MARKET FOR ANALYTICS, BY REGION,.
2024–2031 (USD MILLION) 131.
TABLE 42 ENTERPRISE IMAGING IT MARKET FOR OTHER FUNCTIONS,.
BY REGION, 2024–2031 (USD MILLION) 132.
TABLE 43 ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024–2031 (USD MILLION) 134.
TABLE 44 ENTERPRISE IMAGING IT MARKET FOR X-RAY, BY REGION,.
2024–2031 (USD MILLION) 135.
TABLE 45 ENTERPRISE IMAGING IT MARKET FOR MRI, BY REGION,.
2024–2031 (USD MILLION) 137.
TABLE 46 ENTERPRISE IMAGING IT MARKET FOR CT, BY REGION,.
2024–2031 (USD MILLION) 138.
TABLE 47 ENTERPRISE IMAGING IT MARKET FOR ULTRASOUND, BY REGION,.
2024–2031 (USD MILLION) 139.
TABLE 48 ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,.
2024–2031 (USD MILLION) 140.
TABLE 49 ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY REGION,.
2024–2031 (USD MILLION) 141.
TABLE 50 ENTERPRISE IMAGING IT MARKET FOR PET, BY REGION,.
2024–2031 (USD MILLION) 142.
TABLE 51 ENTERPRISE IMAGING IT MARKET FOR SPECT, BY REGION,.
2024–2031 (USD MILLION) 142.
TABLE 52 ENTERPRISE IMAGING IT MARKET FOR ENDOSCOPY, BY REGION,.
2024–2031 (USD MILLION) 143.
TABLE 53 ENTERPRISE IMAGING IT MARKET FOR MAMMOGRAPHY, BY REGION,.
2024–2031 (USD MILLION) 144.
TABLE 54 ENTERPRISE IMAGING IT MARKET FOR FLUOROSCOPY, BY REGION,.
2024–2031 (USD MILLION) 146.
TABLE 55 ENTERPRISE IMAGING IT MARKET FOR ECHOCARDIOGRAPHY,.
BY REGION, 2024–2031 (USD MILLION) 147.
TABLE 56 ENTERPRISE IMAGING IT MARKET FOR OTHER MODALITIES,.
BY REGION, 2024–2031 (USD MILLION) 148.
TABLE 57 ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 150.
TABLE 58 ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC APPLICATIONS,.
BY REGION, 2024–2031 (USD MILLION) 151.
TABLE 59 ENTERPRISE IMAGING IT MARKET FOR THERAPEUTIC APPLICATIONS,.
BY REGION, 2024–2031 (USD MILLION) 152.
TABLE 60 ENTERPRISE IMAGING IT MARKET FOR CLINICAL RESEARCH APPLICATIONS,.
BY REGION, 2024–2031 (USD MILLION) 153.
TABLE 61 ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 155.
TABLE 62 ENTERPRISE IMAGING IT MARKET FOR SOFTWARE, BY REGION,.
2024–2031 (USD MILLION) 156.
TABLE 63 ENTERPRISE IMAGING IT MARKET FOR SERVICES, BY REGION,.
2024–2031 (USD MILLION) 157.
TABLE 64 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 159.
TABLE 65 ENTERPRISE IMAGING IT MARKET FOR ON-PREMISES SOLUTIONS,.
BY REGION, 2024–2031 (USD MILLION) 160.
TABLE 66 ENTERPRISE IMAGING IT MARKET FOR CLOUD-BASED SOLUTIONS,.
BY REGION, 2024–2031 (USD MILLION) 161.
TABLE 67 ENTERPRISE IMAGING IT MARKET FOR HYBRID SOLUTIONS,.
BY REGION, 2024–2031 (USD MILLION) 162.
TABLE 68 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 164.
TABLE 69 ENTERPRISE IMAGING IT MARKET FOR NEUROLOGY, BY REGION,.
2024–2031 (USD MILLION) 165.
TABLE 70 ENTERPRISE IMAGING IT MARKET FOR CARDIOLOGY, BY REGION,.
2024–2031 (USD MILLION) 166.
TABLE 71 ENTERPRISE IMAGING IT MARKET FOR ONCOLOGY, BY REGION,.
2024–2031 (USD MILLION) 168.
TABLE 72 ENTERPRISE IMAGING IT MARKET FOR ORTHOPEDICS, BY REGION,.
2024–2031 (USD MILLION) 169.
TABLE 73 ENTERPRISE IMAGING IT MARKET FOR OTHER THERAPEUTIC AREAS,.
BY REGION, 2024–2031 (USD MILLION) 169.
TABLE 74 ENTERPRISE IMAGING IT MARKET, FOR END USER, 2024–2031 (USD MILLION) 171.
TABLE 75 ENTERPRISE IMAGING IT MARKET FOR HOSPITALS, BY REGION,.
2024–2031 (USD MILLION) 172.
TABLE 76 ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC CENTERS,.
BY REGION, 2024–2031 (USD MILLION) 173.
TABLE 77 ENTERPRISE IMAGING IT MARKET FOR CLINICS & OUTPATIENT SETTINGS,.
BY REGION, 2024–2031 (USD MILLION) 174.
TABLE 78 ENTERPRISE IMAGING IT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 175.
TABLE 79 ENTERPRISE IMAGING IT MARKET FOR MEDTECH COMPANIES,.
BY REGION, 2024–2031 (USD MILLION) 176.
TABLE 80 ENTERPRISE IMAGING IT MARKET FOR RESEARCH & ACADEMIC INSTITUTES,.
BY REGION, 2024–2031 (USD MILLION) 178.
TABLE 81 ENTERPRISE IMAGING IT MARKET FOR OTHER END USERS,.
BY REGION, 2024–2031 (USD MILLION) 179.
TABLE 82 ENTERPRISE IMAGING IT MARKET, BY REGION, 2024–2031 (USD MILLION) 181.
TABLE 83 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 183.
TABLE 84 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 183.
TABLE 85 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 184.
TABLE 86 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 184.
TABLE 87 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 185.
TABLE 88 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 185.
TABLE 89 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 185.
TABLE 90 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 186.
TABLE 91 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 186.
TABLE 92 US: KEY MACROINDICATORS 188.
TABLE 93 US: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 188.
TABLE 94 US: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024–2031 (USD MILLION) 189.
TABLE 95 US: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 189.
TABLE 96 US: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 190.
TABLE 97 US: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 190.
TABLE 98 US: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 190.
TABLE 99 US: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 191.
TABLE 100 US: ENTERPRISE IMAGING IT MARKET, BY END USER, 2024–2031 (USD MILLION) 191.
TABLE 101 CANADA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 193.
TABLE 102 CANADA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 193.
TABLE 103 CANADA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 194.
TABLE 104 CANADA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 194.
TABLE 105 CANADA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 194.
TABLE 106 CANADA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 195.
TABLE 107 CANADA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 195.
TABLE 108 CANADA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 196.
TABLE 109 EUROPE: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 197.
TABLE 110 EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 197.
TABLE 111 EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 198.
TABLE 112 EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 198.
TABLE 113 EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 199.
TABLE 114 EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 199.
TABLE 115 EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 199.
TABLE 116 EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 200.
TABLE 117 EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 200.
TABLE 118 GERMANY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 202.
TABLE 119 GERMANY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 202.
TABLE 120 GERMANY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 203.
TABLE 121 GERMANY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 203.
TABLE 122 GERMANY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 203.
TABLE 123 GERMANY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 204.
TABLE 124 GERMANY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 204.
TABLE 125 GERMANY: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 205.
TABLE 126 UK: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 206.
TABLE 127 UK: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024–2031 (USD MILLION) 206.
TABLE 128 UK: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 129 UK: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 207.
TABLE 130 UK: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024–2031 (USD MILLION) 207.
TABLE 131 UK: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 208.
TABLE 132 UK: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 208.
TABLE 133 UK: ENTERPRISE IMAGING IT MARKET, BY END USER, 2024–2031 (USD MILLION) 209.
TABLE 135 FRANCE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 210.
TABLE 136 FRANCE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 210.
TABLE 137 FRANCE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 138 FRANCE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 211.
TABLE 139 FRANCE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 211.
TABLE 140 FRANCE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 212.
TABLE 141 FRANCE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 212.
TABLE 142 FRANCE: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 213.
TABLE 144 ITALY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 214.
TABLE 145 ITALY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 214.
TABLE 146 ITALY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 215.
TABLE 147 ITALY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 215.
TABLE 148 ITALY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 215.
TABLE 149 ITALY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 216.
TABLE 150 ITALY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 216.
TABLE 151 ITALY: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 217.
TABLE 152 SPAIN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 218.
TABLE 153 SPAIN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 218.
TABLE 154 SPAIN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 155 SPAIN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 219.
TABLE 156 SPAIN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 219.
TABLE 157 SPAIN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 220.
TABLE 158 SPAIN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 220.
TABLE 159 SPAIN: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 221.
TABLE 160 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 222.
TABLE 161 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 222.
TABLE 163 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 164 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 223.
TABLE 165 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 223.
TABLE 166 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 224.
TABLE 167 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 224.
TABLE 168 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 225.
TABLE 169 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 227.
TABLE 170 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 227.
TABLE 171 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 228.
TABLE 172 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 228.
TABLE 173 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 229.
TABLE 174 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 229.
TABLE 175 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 229.
TABLE 176 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 230.
TABLE 177 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 230.
TABLE 178 CHINA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 231.
TABLE 179 CHINA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 232.
TABLE 180 CHINA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 232.
TABLE 181 CHINA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 233.
TABLE 182 CHINA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 233.
TABLE 183 CHINA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 233.
TABLE 184 CHINA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 234.
TABLE 185 CHINA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 234.
TABLE 186 JAPAN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 236.
TABLE 187 JAPAN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 236.
TABLE 188 JAPAN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 237.
TABLE 189 JAPAN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 237.
TABLE 190 JAPAN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 237.
TABLE 191 JAPAN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 238.
TABLE 192 JAPAN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 238.
TABLE 193 JAPAN: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 239.
TABLE 194 INDIA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 240.
TABLE 195 INDIA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 240.
TABLE 196 INDIA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 241.
TABLE 197 INDIA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 241.
TABLE 198 INDIA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 241.
TABLE 199 INDIA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 242.
TABLE 200 INDIA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 242.
TABLE 201 INDIA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 243.
TABLE 202 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 244.
TABLE 203 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 244.
TABLE 204 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 245.
TABLE 205 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 245.
TABLE 206 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 245.
TABLE 207 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 246.
TABLE 208 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 246.
TABLE 209 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 247.
TABLE 210 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 248.
TABLE 211 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 248.
TABLE 212 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 249.
TABLE 213 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 249.
TABLE 214 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 250.
TABLE 215 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 250.
TABLE 216 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 250.
TABLE 217 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 251.
TABLE 218 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 251.
TABLE 219 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 252.
TABLE 220 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 253.
TABLE 221 BRAZIL: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 253.
TABLE 222 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 254.
TABLE 223 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 254.
TABLE 224 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 254.
TABLE 225 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 255.
TABLE 226 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 255.
TABLE 227 MEXICO: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 257.
TABLE 228 MEXICO: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 257.
TABLE 229 MEXICO: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 258.
TABLE 230 MEXICO: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 258.
TABLE 231 MEXICO: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 258.
TABLE 232 MEXICO: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,.
2024–2031 (USD MILLION) 259.
TABLE 233 MEXICO: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,.
2024–2031 (USD MILLION) 259.
TABLE 234 MEXICO: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 260.
TABLE 235 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 261.
TABLE 236 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY MODALITY, 2024–2031 (USD MILLION) 261.
TABLE 237 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 262.
TABLE 238 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 262.
TABLE 239 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 262.
TABLE 240 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 263.
TABLE 241 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 263.
TABLE 242 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 264.
TABLE 243 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY COUNTRY, 2024–2031 (USD MILLION) 265.
TABLE 244 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 266.
TABLE 245 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY MODALITY, 2024–2031 (USD MILLION) 266.
TABLE 246 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 267.
TABLE 247 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 267.
TABLE 248 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 267.
TABLE 249 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 268.
TABLE 250 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 268.
TABLE 251 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 269.
TABLE 252 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 270.
TABLE 253 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY MODALITY,.
2024–2031 (USD MILLION) 270.
TABLE 254 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,.
BY TYPE, 2024–2031 (USD MILLION) 271.
TABLE 255 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,.
2024–2031 (USD MILLION) 271.
TABLE 256 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 271.
TABLE 257 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 272.
TABLE 258 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 272.
TABLE 259 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY END USER,.
2024–2031 (USD MILLION) 273.
TABLE 260 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 274.
TABLE 261 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY MODALITY, 2024–2031 (USD MILLION) 274.
TABLE 262 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 275.
TABLE 263 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY APPLICATION, 2024–2031 (USD MILLION) 275.
TABLE 264 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 275.
TABLE 265 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY DEPLOYMENT MODE, 2024–2031 (USD MILLION) 276.
TABLE 266 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 276.
TABLE 267 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,.
BY END USER, 2024–2031 (USD MILLION) 277.
TABLE 268 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023–2026 279.
TABLE 269 ENTERPRISE IMAGING IT MARKET: DEGREE OF COMPETITION 283.
TABLE 270 ENTERPRISE IMAGING IT MARKET: REGION FOOTPRINT 289.
TABLE 271 ENTERPRISE IMAGING IT MARKET: FUNCTION FOOTPRINT 290.
TABLE 272 ENTERPRISE IMAGING IT MARKET: APPLICATION FOOTPRINT 291.
TABLE 273 ENTERPRISE IMAGING IT MARKET: THERAPEUTIC FOOTPRINT 292.
TABLE 274 ENTERPRISE IMAGING IT MARKET: DEPLOYMENT FOOTPRINT 293.
TABLE 275 ENTERPRISE IMAGING IT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 296.
TABLE 276 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 296.
TABLE 277 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY FUNCTION 297.
TABLE 278 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY THERAPEUTIC AREA 297.
TABLE 279 ENTERPRISE IMAGING IT MARKET: SOLUTION LAUNCHES & ENHANCEMENT, JANUARY 2023–OCTOBER 2026 300.
TABLE 280 ENTERPRISE IMAGING IT MARKET: DEALS, JANUARY 2023–OCTOBER 2026 301.
TABLE 281 ENTERPRISE IMAGING IT MARKET: EXPANSIONS, JANUARY 2023–OCTOBER 2026 302.
TABLE 282 ENTERPRISE IMAGING IT MARKET: OTHER DEVELOPMENTS, JANUARY 2023–OCTOBER 2026 303.
TABLE 283 AGFA-GEVAERT GROUP: COMPANY OVERVIEW 304.
TABLE 284 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED 305.
TABLE 285 AGFA-GEVAERT GROUP: DEALS, JANUARY 2023–OCTOBER 2026 307.
TABLE 286 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 310.
TABLE 287 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED 312.
TABLE 288 FUJIFILM HOLDINGS CORPORATION: SOLUTION LAUNCHES,.
JANUARY 2023–OCTOBER 2026 313.
TABLE 289 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023–OCTOBER 2026 313.
TABLE 290 GE HEALTHCARE: COMPANY OVERVIEW 316.
TABLE 291 GE HEALTHCARE: SOLUTIONS OFFERED 317.
TABLE 292 GE HEALTHCARE: SOLUTION LAUNCHES & APPROVALS,.
JANUARY 2023–OCTOBER 2026 320.
TABLE 293 GE HEALTHCARE: DEALS, JANUARY 2023–OCTOBER 2026 321.
TABLE 294 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 324.
TABLE 295 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED 325.
TABLE 296 KONINKLIJKE PHILIPS N.V.: SOLUTION LAUNCHES & APPROVALS,.
JANUARY 2023–OCTOBER 2026 327.
TABLE 297 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–OCTOBER 2026 328.
TABLE 298 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023–OCTOBER 2026 329.
TABLE 299 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 331.
TABLE 300 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED 332.
TABLE 301 SIEMENS HEALTHINEERS AG: SOLUTION LAUNCHES,.
JANUARY 2023–OCTOBER 2026 335.
TABLE 302 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023–OCTOBER 2026 335.
TABLE 303 SECTRA AB: COMPANY OVERVIEW 338.
TABLE 304 SECTRA AB: SOLUTIONS OFFERED 339.
TABLE 305 SECTRA AB: SOLUTION LAUNCHES & APPROVALS, JANUARY 2023–OCTOBER 2026 342.
TABLE 306 SECTRA AB: DEALS, JANUARY 2023–OCTOBER 2026 342.
TABLE 307 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2023–OCTOBER 2026 344.
TABLE 308 OPTUM, INC.: COMPANY OVERVIEW 345.
TABLE 309 OPTUM, INC.: SOLUTIONS OFFERED 346.
TABLE 310 OPTUM, INC.: DEALS, JANUARY 2023–OCTOBER 2026 347.
TABLE 311 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 348.
TABLE 312 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED 350.
TABLE 313 CANON MEDICAL SYSTEMS CORPORATION: DEALS,.
JANUARY 2023–OCTOBER 2026 350.
TABLE 314 MERATIVE: COMPANY OVERVIEW 351.
TABLE 315 MERATIVE: SOLUTIONS OFFERED 351.
TABLE 316 MERATIVE: SOLUTION LAUNCHES, JANUARY 2023–OCTOBER 2026 352.
TABLE 317 MERATIVE: DEALS, JANUARY 2023–OCTOBER 2026 352.
TABLE 318 MERATIVE: EXPANSIONS, JANUARY 2023–OCTOBER 2026 353.
TABLE 319 PRO MEDICUS, LTD.: COMPANY OVERVIEW 354.
TABLE 320 PRO MEDICUS, LTD.: SOLUTIONS OFFERED 356.

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/11/19 10:27

160.48 円

176.53 円

213.76 円

ページTOPに戻る